Shuangyan Yang

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysis.

Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysis.

Journal: Translational lung cancer research

Published: April 10, 2025

Precision Stereotactic Body Radiotherapy for Ultra-Central NSCLC: Tailored Margins Reduce Toxicity Without Compromising Tumor Control.

Precision Stereotactic Body Radiotherapy for Ultra-Central NSCLC: Tailored Margins Reduce Toxicity Without Compromising Tumor Control.

Journal: MedComm

Published: February 28, 2025

Reducing radiation pneumonitis in lung cancer patients: from Chinese expert consensus to practice.

Reducing radiation pneumonitis in lung cancer patients: from Chinese expert consensus to practice.

Journal: Translational lung cancer research

Published: February 11, 2025

Application of respiratory motion management technology for patients with lung cancer treated with stereotactic body radiotherapy (Review).

Application of respiratory motion management technology for patients with lung cancer treated with stereotactic body radiotherapy (Review).

Journal: Oncology letters

Published: February 06, 2025

Quantitative evaluation of accumulated and planned dose deviations in patients undergoing gated and non-gated lung stereotactic body radiation therapy patients: a retrospective analysis.

Quantitative evaluation of accumulated and planned dose deviations in patients undergoing gated and non-gated lung stereotactic body radiation therapy patients: a retrospective analysis.

Journal: Translational lung cancer research

Published: October 23, 2024

Clinical predictors of severe radiation pneumonitis in patients undergoing thoracic radiotherapy for lung cancer.

Clinical predictors of severe radiation pneumonitis in patients undergoing thoracic radiotherapy for lung cancer.

Journal: Translational lung cancer research

Published: April 12, 2024

Author Correction: A comparative study of auto-contouring softwares in delineation of organs at risk in lung cancer and rectal cancer.

Author Correction: A comparative study of auto-contouring softwares in delineation of organs at risk in lung cancer and rectal cancer.

Journal: Scientific reports

Published: February 12, 2024

Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non-small cell lung cancer: a multi-institutional retrospective cohort study.

Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non-small cell lung cancer: a multi-institutional retrospective cohort study.

Journal: MedComm

Published: May 28, 2023

Five-year follow-up after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer: a multicenter study.

Five-year follow-up after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer: a multicenter study.

Journal: Translational lung cancer research

Published: May 04, 2023

Effect and stability of miniscrew-assisted rapid palatal expansion: A systematic review and meta-analysis.

Effect and stability of miniscrew-assisted rapid palatal expansion: A systematic review and meta-analysis.

Journal: Korean journal of orthodontics

Published: December 16, 2021

A comparative study of auto-contouring softwares in delineation of organs at risk in lung cancer and rectal cancer.

A comparative study of auto-contouring softwares in delineation of organs at risk in lung cancer and rectal cancer.

Journal: Scientific reports

Published: June 04, 2021

Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study.

Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study.

Journal: Annals of translational medicine

Published: November 19, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026